Correlation Between Neurocrine Biosciences and STRYKER
Specify exactly 2 symbols:
By analyzing existing cross correlation between Neurocrine Biosciences and STRYKER P 35, you can compare the effects of market volatilities on Neurocrine Biosciences and STRYKER and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of STRYKER. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and STRYKER.
Diversification Opportunities for Neurocrine Biosciences and STRYKER
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Neurocrine and STRYKER is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and STRYKER P 35 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on STRYKER P 35 and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with STRYKER. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of STRYKER P 35 has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and STRYKER go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and STRYKER
If you would invest (100.00) in STRYKER P 35 on December 30, 2024 and sell it today you would earn a total of 100.00 from holding STRYKER P 35 or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Neurocrine Biosciences vs. STRYKER P 35
Performance |
Timeline |
Neurocrine Biosciences |
STRYKER P 35 |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Neurocrine Biosciences and STRYKER Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neurocrine Biosciences and STRYKER
The main advantage of trading using opposite Neurocrine Biosciences and STRYKER positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, STRYKER can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STRYKER will offset losses from the drop in STRYKER's long position.Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
STRYKER vs. Cabo Drilling Corp | STRYKER vs. NetSol Technologies | STRYKER vs. Zhihu Inc ADR | STRYKER vs. Noble plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |